Nervous system disorders: Very rare: Change in taste sensations.
Gastrointestinal disorders: Very rare: Nausea, vomiting, gastrointestinal pain and diarrhoea.
Immune system disorders: Very rare: Allergic reactions (such as skin rash, hives (urticaria) and itching), insulin autoimmune syndrome.
Not known: Insulin autoimmune syndrome (see Precautions).
Metabolism and nutrition disorders: Very rare: Because of improved glucose utilization, a fall in blood sugar levels may occur.
Symptoms similar to those of hypoglycaemia have been described such as vertigo, diaphoresis, headache and altered visual perception.
Reporting of suspected adverse reactions: Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system.
View ADR Reporting Link